Cannabidiol (CBD) Hemp Oil recommended by DrPablo

Brain Cancer

1. A study published in the British Journal of Cancer, conducted by the Department of Biochemistry and Molecular Biology at Complutense University in Madrid, this study determined that Tetrahydrocannabinol (THC) and other cannabinoids inhibit tumour growth. They were responsible for the first clinical study aimed at assessing cannabinoid antitumoral action. Cannabinoid delivery was safe and was achieved with zero psychoactive effects. THC was found to decrease tumour cells in two out of the nine patients.

2. A study published in The Journal of Neuroscience examined the biochemical events in both acute neuronal damage and in slowly progressive, neurodegenerative diseases. They conducted a magnetic resonance imaging study that looked at THC (the main active compound in marijuana) and found that it reduced neuronal injury in rats. The results of this study provide evidence that the cannabinoid system can serve to protect the brain against neurodegeneration.

3. A study published in The Journal of Pharmacology And Experimental Therapeutics already acknowledged the fact that cannabinoids have been shown to possess anti-tumor properties. This study examined the effect of cannabidiol (CBD, non psychoactive cannabinoid compound) on human glioma cell lines. The addition of cannabidiol led to a dramatic drop in the viability of glioma cells. Glioma is the word used to describe brain tumour. The study concluded that cannabidiol was able to produce a significant antitumor activity.

4. A study published in the journal Molecular Cancer Therapeutics outlines how brain tumours are highly resistant to current anticancer treatments, which makes it crucial to find new therapeutic strategies aimed at improving the poor prognosis of patients suffering from this disease. This study also demonstrated the reversal of tumour activity in Glioblastoma multiforme.
Breast Cancer

5. A study published in the US National Library of Medicine, conducted by the California Pacific Medical Centre determined that cannabidiol (CBD) inhibits human breast cancer cell proliferation and invasion. They also demonstrated that CBD significantly reduces tumour mass.

6. A study published in The Journal of Pharmacology and Experimental Therapeutics determined that THC as well as cannabidiol dramatically reduced breast cancer cell growth. They confirmed the potency and effectiveness of these compounds.

7. A study published in the Journal Molecular Cancer showed that THC reduced tumour growth and tumour numbers. They determined that cannabinoids inhibit cancer cell proliferation, induce cancer cell apoptosis and impair tumour angiogenesis (all good things). This study provides strong evidence for the use of cannabinoid based therapies for the management of breast cancer.

8. A study published in the Proceedings of the National Academy of Sciences of the United States of America (PNAS) determined that cannabinoids inhibit human breast cancer cell proliferation.
Lung Cancer

9. A study published in the journal Oncogene, by Harvard Medical Schools Experimental Medicine Department determined that THC inhibits epithelial growth factor induced lung cancer cell migration and more. They go on to state that THC should be explored as novel therapeutic molecules in controlling the growth and metastasis of certain lung cancers.

10. A study published by the US National Library of Medicine by the Institute of Toxicology and Pharmacology, from the Department of General Surgery in Germany determined that cannabinoids inhibit cancer cell invasion. Effects were confirmed in primary tumour cells from a lung cancer patient. Overall, data indicated that cannabinoids decrease cancer cell invasiveness.

11. A study published by the US National Library of Medicine, conducted by Harvard Medical School investigated the role of cannabinoid receptors in lung cancer cells. They determined its effectiveness and suggested that it should be used for treatment against lung cancer cells.

Prostate Cancer

12. A study published in the US National Library of Medicine illustrates a decrease in prostatic cancer cells by acting through cannabinoid receptors.

13. A study published in the US National Library of Medicine outlined multiple studies proving the effectiveness of cannabis on prostate cancer.

14. Another study published by the US National Library of Medicine determined that clinical testing of CBD against prostate carcinoma is a must. That cannabinoid receptor activation induces prostate carcinoma cell apoptosis. They determined that cannabidiol significantly inhibited cell viability.

Blood Cancer

15. A study published in the journal Molecular Pharmacology recently showed that cannabinoids induce growth inhibition and apoptosis in matle cell lymphoma. The study was supported by grants from the Swedish Cancer Society, The Swedish Research Council and the Cancer Society in Stockholm.

16. A study published in the International Journal of Cancer also determined and illustrated that cannabinoids exert antiproliferative and proapoptotic effects in various types of cancer and in mantle cell lymphoma.

17. A study published in the US National Library of Medicine conducted by the Department of Pharmacology and Toxicology by Virginia Commonwealth University determined that cannabinoids induce apoptosis in leukemia cells.

Oral Cancer

18. A study published by the US National Library of Medicine results show cannabinoids are potent inhibitors of cellular respiration and are toxic to highly malignant oral Tumours.

Liver Cancer

19. A study published by the US National Library of Medicine determined that that THC reduces the viability of human HCC cell lines (Human hepatocellular liver carcinoma cell line) and reduced the growth.

Pancreatic Cancer

20. A study published in The American Journal of Cancer determined that cannabinoid receptors are expressed in human pancreatic tumor cell lines and tumour biopsies at much higher levels than in normal pancreatic tissue. Results showed that cannabinoid administration induced apoptosis. They also reduced the growth of tumour cells, and inhibited the spreading of pancreatic tumour cells.

Sources:

All sources highlighted throughout article. Click on the highlighted parts of the article to view them.

1)http://bjp.rcpsych.org/content/178/2/116.full

Brain Cancer

1. A study published in the British Journal of Cancer, conducted by the Department of Biochemistry and Molecular Biology at Complutense University in Madrid, this study determined that Tetrahydrocannabinol (THC) and other cannabinoids inhibit tumour growth. They were responsible for the first clinical study aimed at assessing cannabinoid antitumoral action. Cannabinoid delivery was safe and was achieved with zero psychoactive effects. THC was found to decrease tumour cells in two out of the nine patients.

2. A study published in The Journal of Neuroscience examined the biochemical events in both acute neuronal damage and in slowly progressive, neurodegenerative diseases. They conducted a magnetic resonance imaging study that looked at THC (the main active compound in marijuana) and found that it reduced neuronal injury in rats. The results of this study provide evidence that the cannabinoid system can serve to protect the brain against neurodegeneration.

3. A study published in The Journal of Pharmacology And Experimental Therapeutics already acknowledged the fact that cannabinoids have been shown to possess antitumor properties. This study examined the effect of cannabidiol (CBD, non psychoactive cannabinoid compound) on human glioma cell lines. The addition of cannabidiol led to a dramatic drop in the viability of glioma cells. Glioma is the word used to describe brain tumour. The study concluded that cannabidiol was able to produce a significant antitumor activity.

4. A study published in the journal Molecular Cancer Therapeutics outlines how brain tumours are highly resistant to current anticancer treatments, which makes it crucial to find new therapeutic strategies aimed at improving the poor prognosis of patients suffering from this disease. This study also demonstrated the reversal of tumour activity in Glioblastoma multiforme.
Breast Cancer

5. A study published in the US National Library of Medicine, conducted by the California Pacific Medical Centre determined that cannabidiol (CBD) inhibits human breast cancer cell proliferation and invasion. They also demonstrated that CBD significantly reduces tumour mass.

6. A study published in The Journal of Pharmacology and Experimental Therapeutics determined that THC as well as cannabidiol dramatically reduced breast cancer cell growth. They confirmed the potency and effectiveness of these compounds.

7. A study published in the Journal Molecular Cancer showed that THC reduced tumour growth and tumour numbers. They determined that cannabinoids inhibit cancer cell proliferation, induce cancer cell apoptosis and impair tumour angiogenesis (all good things). This study provides strong evidence for the use of cannabinoid based therapies for the management of breast cancer.

8. A study published in the Proceedings of the National Academy of Sciences of the United States of America (PNAS) determined that cannabinoids inhibit human breast cancer cell proliferation.
Lung Cancer

9. A study published in the journal Oncogene, by Harvard Medical Schools Experimental Medicine Department determined that THC inhibits epithelial growth factor induced lung cancer cell migration and more. They go on to state that THC should be explored as novel therapeutic molecules in controlling the growth and metastasis of certain lung cancers.

10. A study published by the US National Library of Medicine by the Institute of Toxicology and Pharmacology, from the Department of General Surgery in Germany determined that cannabinoids inhibit cancer cell invasion. Effects were confirmed in primary tumour cells from a lung cancer patient. Overall, data indicated that cannabinoids decrease cancer cell invasiveness.

11. A study published by the US National Library of Medicine, conducted by Harvard Medical School investigated the role of cannabinoid receptors in lung cancer cells. They determined its effectiveness and suggested that it should be used for treatment against lung cancer cells.
Prostate Cancer

12. A study published in the US National Library of Medicine illustrates a decrease in prostatic cancer cells by acting through cannabinoid receptors.

13. A study published in the US National Library of Medicine outlined multiple studies proving the effectiveness of cannabis on prostate cancer.

14. Another study published by the US National Library of Medicine determined that clinical testing of CBD against prostate carcinoma is a must. That cannabinoid receptor activation induces prostate carcinoma cell apoptosis. They determined that cannabidiol significantly inhibited cell viability.
Blood Cancer

15. A study published in the journal Molecular Pharmacology recently showed that cannabinoids induce growth inhibition and apoptosis in matle cell lymphoma. The study was supported by grants from the Swedish Cancer Society, The Swedish Research Council and the Cancer Society in Stockholm.

16. A study published in the International Journal of Cancer also determined and illustrated that cannabinoids exert antiproliferative and proapoptotic effects in various types of cancer and in mantle cell lymphoma.

17. A study published in the US National Library of Medicine conducted by the Department of Pharmacology and Toxicology by Virginia Commonwealth University determined that cannabinoids induce apoptosis in leukemia cells.
Oral Cancer

18. A study published by the US National Library of Medicine results show cannabinoids are potent inhibitors of cellular respiration and are toxic to highly malignant oral Tumours.
Liver Cancer

19. A study published by the US National Library of Medicine determined that that THC reduces the viability of human HCC cell lines (Human hepatocellular liver carcinoma cell line) and reduced the growth.
Pancreatic Cancer

20. A study published in The American Journal of Cancer determined that cannabinoid receptors are expressed in human pancreatic tumor cell lines and tumour biopsies at much higher levels than in normal pancreatic tissue. Results showed that cannabinoid administration induced apoptosis. They also reduced the growth of tumour cells, and inhibited the spreading of pancreatic tumour cells.

Sources:

All sources highlighted throughout article. Click on the highlighted parts of the article to view them.

1)http://bjp.rcpsych.org/content/178/2/116.full
– See more at: http://www.collective-evolution.com/2013/08/23/20-medical-studies-that-prove-cannabis-can-cure-cancer/#sthash.Qb6kmjwZ.dpuf

 

All sources highlighted throughout article. Click on the highlighted parts of the article to view them.

1)http://bjp.rcpsych.org/content/178/2/116.full
– See more at: http://www.collective-evolution.com/2013/08/23/20-medical-studies-that-prove-cannabis-can-cure-cancer/#sthash.Qb6kmjwZ.dpuf

What Is CBD?
http://youtu.be/g79HokJTfPU
Click Here for Video

 

If you have found yourself asking, “What is CBD?”, look no further. Cannabidiol (CBD) is one of at least 85 cannabinoids found in cannabis and industrial hemp. It is a major constituent of the plant, and represents up to 40% in its extracts. It is the decarboxylated form of CBDa (the ‘a’ means acid). Compared with THC, cannabidiol is considered to have a broader scope of medical applications than THC. Cannabidiol has displayed sedative effects in animal tests. Other research indicates that CBD increases alertness. CBD has been shown to reduce growth of aggressive human breast cancer cells in vitro, and to reduce their invasiveness [source].

CBD also promotes and supports the nutritional health of aging bodies. Source: US Government patent on Cannabinoids as Antioxidants and Neuroprotectants #6,630,507

The CBD found in our CBD gum and RSHO Oil is extracted via an advanced steam distillation process from high CBD industrial hemp.
Some Potential Medical Benefits of CBD:

Image courtesy of SC Laboratories

CBD has been found to be anti-spasmodic and antiepileptic, which could be beneficial for those who suffer from epilepsy, Dravet’s Syndrome, Multiple Sclerosis (MS), ALS, among others.
At high doses (more than several hundred mg) CBD can be a sedative, and also helps insomniacs stay asleep longer. In low doses, CBD has been found to be alerting.
CBD is effective as an anti-inflammatory, anti-anxiety (anxiolytic) and relieving for nausea (anti-emetic)
CBD is a powerful pain reliever (analgesic)
CBD has been shown to inhibit cancer cell growth (anti-carcinogenic).
CBD helps the immune system function more efficiently.
CBD is a neuroprotectant and a powerful antioxidant. It has applications in treatment for Alzheimer’s, Parkinsons, cerebral ischemia as well as brain and nerve damage from strokes.
CBD is an anti-psychotic and recent research has indicated it is effective in treatment of schizophrenia.
CBD could be effective in easing symptoms of a wide range of difficult-to-control conditions, including: rheumatoid arthritis, diabetes, alcoholism, PTSD, epilepsy, MS, antibiotic-resistant infections and neurological disorders, to name a few.
CBD as been found to be effective in treating gastrointestinal disorders like Irritable Bowel Disorder (IBD), Crohn’s Disease, or Ulcertative Colitis.
CBD has shown some inclination to being beneficial for those with autism

Scientific references:

Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb
Angelo A. Izzo, Francesca Borrelli, Raffaele Capasso, Vincenzo Di Marzo and Raphael Mechoulam
http://www.ncbi.nlm.nih.gov/pubmed/19729208
Org. Biomol. Chem., 2005, 3, 1116 – 1123
Cannabinoids: potential anticancer agents. Nat Rev Cancer. 2003 Oct; 3(10):745-55.
Guzmán Manuel, Department of Biochemistry and Molecular Biology I, School of Biology,
Complutense University, 28040 Madrid, Spain
http://www.brainlife.org/reprint/2003/guzm%C3%A1n_m031000.pdf
Enantiomeric cannabidiol derivatives: synthesis and binding to cannabinoid receptors Lumír O. Hanu, Susanna Tchilibon, Datta E. Ponde, Aviva Breuer,
Ester Fride and Raphael Mechoulam
http://www.ncbi.nlm.nih.gov/pubmed/15750656
Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action
Antonio Waldo Zuardi
Department of Neurology, Psychiatry and Medical Psychology,
Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo (USP), Brazil
http://www.scielo.br/pdf/rbp/v30n3/a15v30n3.pdf
MECHOULAM ON CANNABIDIOL From O’Shaughnessy’s // Winter/Spring 2008
http://projectcbd.org/MechoulamOnCannabidiol.html#Mechoulam
If you have found yourself asking, “What is CBD?”, look no further. Cannabidiol (CBD) is one of at least 85 cannabinoids found in cannabis and industrial hemp. It is a major constituent of the plant, and represents up to 40% in its extracts. It is the decarboxylated form of CBDa (the ‘a’ means acid). Compared with THC, cannabidiol is considered to have a broader scope of medical applications than THC. Cannabidiol has displayed sedative effects in animal tests. Other research indicates that CBD increases alertness. CBD has been shown to reduce growth of aggressive human breast cancer cells in vitro, and to reduce their invasiveness [source].

CBD also promotes and supports the nutritional health of aging bodies. Source: US Government patent on Cannabinoids as Antioxidants and Neuroprotectants #6,630,507

The CBD found in our CBD gum and RSHO Oil is extracted via an advanced steam distillation process from high CBD industrial hemp.

Hemp is a plant that has been used for thousands of years for various aspects of survival. Industrial hemp is amazingly versatile and is capable of producing food, fuel and fiber that is used in countless applications including textiles, paper, and composites for manufacturing.

Extremely suitable for cultivation in a wide range of climates and soils, hemp requires less fertilizer and pesticide than any other commercial crop and is a far superior plant to recondition soil for further cultivation.

Our founding fathers, including George Washington, Benjamin Franklin, and Thomas Jefferson, cultivated hemp. The Declaration of Independence was originally written on hemp paper. The first American flag was made of hemp. The sails and lines of naval fleets were made of hemp fibers. The pioneers covered their wagons with canvas made of hemp. Hemp has played an integral part of American history. In fact, it was once illegal NOT to grow industrial hemp.

“Hemp is of first necessity to the wealth and protection of the country” – Thomas Jefferson, U.S. President.

Containing less than 1% THC, the psychoactive ingredient in Cannabis Sativa Linnaeus, hemp is to marijuana as non alcoholic beer is to beer.

Hemp seeds, oil and protein are classified as “super foods” with nutritional values unrivaled in nature and only recently introduced into the American marketplace. Hemp seeds have ten of the essential amino acids and high concentrations of Omega 3, 6 and 9 essential fatty acids, in an ideal ratio, making it one of the most valuable whole foods found anywhere. Did you know that hemp seed oil is used in the production of non dairy milk, cheese, bread and butter.

Hemp is the world’s strongest fiber, and was the first crop cultivated for textile production dating back well over 6,000 years.

Hemp composite boards are twice as strong as wood. As a composite material for automobiles, this remarkable plant fiber is also twice as strong at lighter weights as fiberglass type components. Other applications include use as oils, soaps, lotions, cosmetics, supplements, veterinary applications, construction and fiberglass components.

Hemp yields approximately three tons of fiber per acre, four times the amount produced by trees, saving wildlife habitat, watersheds, oxygen production, and proving its value as a green, renewable Earth friendly resource.

“Why use up the forest which were centuries in making and the mines which required ages to lie down, if we can get the equivalent of forest and mineral products in the annual growth of the hemp fields?” – Henry Ford.

President Don Steinberg

 

FDA Disclaimer Required By Law

These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
It is important to check with your physician before starting a new dietary supplement program.

 xyz-wellbeing-retreat-facility

 

Some Quick Links

THE STORY OF VITAMIN B17 HIGH PH CESIUM THERAPY DETAILS OF HEMP
THE BENEFITS OF DMSO HOME Ozone Therapy
Testimonials

Important WEBSITES you should visit!

Please register on these pages, enjoy the education and contact me if you want help….

https://cancer.atlantis-health-retreat.com/7-days-of-video

https://live-webinar.atlantis-health-retreat.com/webinar-registration-page

https://cancer.atlantis-health-retreat.com/consult-request

Save